These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Optimizing therapy for vancomycin-resistant enterococcal bacteremia in children. Tamma PD; Hsu AJ Curr Opin Infect Dis; 2014 Dec; 27(6):517-27. PubMed ID: 25313503 [TBL] [Abstract][Full Text] [Related]
43. Time-kill curves of daptomycin and Monte Carlo simulation for the treatment of bacteraemia caused by Enterococcus faecium. Menezes BK; Alves IA; Staudt KJ; Beltrame BM; Venz L; Michelin L; Araujo BV; Tasso L Braz J Microbiol; 2020 Mar; 51(1):169-176. PubMed ID: 31845296 [TBL] [Abstract][Full Text] [Related]
44. Emergence of daptomycin-resistant VRE: experience of a single institution. Kamboj M; Cohen N; Gilhuley K; Babady NE; Seo SK; Sepkowitz KA Infect Control Hosp Epidemiol; 2011 Apr; 32(4):391-4. PubMed ID: 21460492 [TBL] [Abstract][Full Text] [Related]
45. Daptomycin in the treatment of enterococcal bloodstream infections and endocarditis: a EUCAST position paper. Turnidge J; Kahlmeter G; Cantón R; MacGowan A; Giske CG; Clin Microbiol Infect; 2020 Aug; 26(8):1039-1043. PubMed ID: 32353412 [TBL] [Abstract][Full Text] [Related]
46. Association of daptomycin use with resistance development in Enterococcus faecium bacteraemia-a 7-year individual and population-based analysis. Egli A; Schmid H; Kuenzli E; Widmer AF; Battegay M; Plagge H; Frei R; Achermann R; Weisser M Clin Microbiol Infect; 2017 Feb; 23(2):118.e1-118.e7. PubMed ID: 27746397 [TBL] [Abstract][Full Text] [Related]
50. Daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bacteremia: systematic review and meta-analysis. Chuang YC; Wang JT; Lin HY; Chang SC BMC Infect Dis; 2014 Dec; 14():687. PubMed ID: 25495779 [TBL] [Abstract][Full Text] [Related]
51. Evaluation of tedizolid against Staphylococcus aureus and enterococci with reduced susceptibility to vancomycin, daptomycin or linezolid. Barber KE; Smith JR; Raut A; Rybak MJ J Antimicrob Chemother; 2016 Jan; 71(1):152-5. PubMed ID: 26476277 [TBL] [Abstract][Full Text] [Related]
52. Bloodstream Infection Due to Vancomycin-resistant Enterococcus Is Associated With Increased Mortality After Hematopoietic Cell Transplantation for Acute Leukemia and Myelodysplastic Syndrome: A Multicenter, Retrospective Cohort Study. Papanicolaou GA; Ustun C; Young JH; Chen M; Kim S; Woo Ahn K; Komanduri K; Lindemans C; Auletta JJ; Riches ML; Clin Infect Dis; 2019 Oct; 69(10):1771-1779. PubMed ID: 30649224 [TBL] [Abstract][Full Text] [Related]
53. Detection of Vancomycin-Resistant McEllistrem MC; Nordstrom HR; Lucas A; Decker BK; Van Tyne D Microb Drug Resist; 2022 Mar; 28(3):382-385. PubMed ID: 34918959 [TBL] [Abstract][Full Text] [Related]
54. Daptomycin for the treatment of enterococcal bacteraemia: results from the Cubicin Outcomes Registry and Experience (CORE). Mohr JF; Friedrich LV; Yankelev S; Lamp KC Int J Antimicrob Agents; 2009 Jun; 33(6):543-8. PubMed ID: 19201165 [TBL] [Abstract][Full Text] [Related]
55. Systematic review and meta-analysis of linezolid and daptomycin for treatment of vancomycin-resistant enterococcal bloodstream infections. Whang DW; Miller LG; Partain NM; McKinnell JA Antimicrob Agents Chemother; 2013 Oct; 57(10):5013-8. PubMed ID: 23896468 [TBL] [Abstract][Full Text] [Related]
56. Observational study of the epidemiology and outcomes of vancomycin-resistant Enterococcus bacteraemia treated with newer antimicrobial agents. McKinnell JA; Patel M; Shirley RM; Kunz DF; Moser SA; Baddley JW Epidemiol Infect; 2011 Sep; 139(9):1342-50. PubMed ID: 21073764 [TBL] [Abstract][Full Text] [Related]
57. In vivo daptomycin efficacy against experimental vancomycin-resistant Enterococcus faecium endocarditis. Reissier S; Saleh-Mghir A; Guerin F; Massias L; Ghout I; Sinel C; Cattoir V; Cremieux AC J Antimicrob Chemother; 2018 Apr; 73(4):981-986. PubMed ID: 29329389 [TBL] [Abstract][Full Text] [Related]
58. Daptomycin for the treatment of bacteraemia due to vancomycin-resistant enterococci. Munita JM; Murray BE; Arias CA Int J Antimicrob Agents; 2014 Nov; 44(5):387-95. PubMed ID: 25261158 [TBL] [Abstract][Full Text] [Related]
59. Daptomycin for the treatment of vancomycin resistant Enterococcus faecium bacteremia. Kvirikadze N; Suseno M; Vescio T; Kaminer L; Singh K Scand J Infect Dis; 2006; 38(4):290-2. PubMed ID: 16709529 [TBL] [Abstract][Full Text] [Related]
60. Evaluation of the novel combination of daptomycin plus ceftriaxone against vancomycin-resistant enterococci in an in vitro pharmacokinetic/pharmacodynamic simulated endocardial vegetation model. Hall Snyder A; Werth BJ; Barber KE; Sakoulas G; Rybak MJ J Antimicrob Chemother; 2014 Aug; 69(8):2148-54. PubMed ID: 24777900 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]